52nd Annual Family Medicine Course

Course fee includes tuition, comprehensive electronic course syllabus, continental breakfast each morning, coffee breaks, and luncheon on Thursday for in-person registrants. 

_{*Verification by Program Director Required.}
 

REFUNDS: Refunds, minus an administrative fee of $75, will be made only if notice of cancellation is received at uvmcmie@med.uvm.edu prior to May 15, 2026.  Refunds are not possible after that date. Substitutions may be possible; please call (802) 656-2292 to inquire.

Tuesday, June 2, 2026

11:45 AM - 1:00 PM   Registration

12:50 - 1:00 PM   Opening Remarks - Anya S. Streeter, MD FAAFP, IBCLC

1:00 - 1:45   Lipedema: It's Not Just Obesity. The Importance of Early Diagnosis and Treatment - Julie Lahiri, MD

1:45 - 2:30   Sleep Disorders in the Elderly - Pamela Swift, PhD

2:30 - 2:45   Break

2:45 - 3:30   The Role of GLP-1 and GLP-1/GIP Medications in the Management of Type 2 Diabetes - Matthew Gilbert, DO, MPH

3:30 - 4:15   Can AI (Help Us) Find Moments of Human Connection in Serious Illness? - Bob Gramling, MD, DSc

4:15 - 5:00   HPV Associated Head and Neck Cancer - Quinn Self, MD

5:00 PM   Adjourn

Wednesday, June 3, 2026

7:30 AM   Continental Breakfast

8:00 - 8:45   Vaccine Update - Jiayu Kate Tian, MD

8:45 - 9:30   Current Guidelines for Screening and Management of Essential Hypertension - Chidinma Enyinna, MD

9:30 - 10:15   Fear Not: Childhood Anxiety & Primary Care - Jeremiah Dickerson, MD

10:15 - 10:30   Break

10:30 - 11:15   Top 10 Things Your Pulmonologist Would Like You to Consider in Primary Care - David Kaminsky, MD

11:15 - 12:00 PM   Urgent Care Grab Bag - Jennifer Bamford, MD

12:00 - 1:30 PM   Lunch (On Your Own)

1:30 - 3:00 Concurrent Sessions I

  POCUS - Introductory Knee and Bladder - Benjamin Clements, MD

  The Metabolic Reset: Clinical Nutrition Pearls for Reversing Insulin Resistance - Whitney Calkins, MD

  Gender Affirming Care: Clinical Cases and FAQ - Anja Jokela, MD; Rachel Inker, MD; Rachel LaRocca, MD

3:00 - 3:30   Break

3:30 - 5:00  Concurrent Sessions II

  POCUS - Intermediate Cardiac - Benjamin Clements, MD

  Identifying and Treating Substance Use Disorders in Primary Care - Katie Marvin, MD

  Polypharmacy in the Older Adult - Kathleen Boland, PharmD; Lauren Bode, PharmD, BCACP, CDCES, BC-ADM; Anne Morris, MD

5:00 PM   Adjourn

Thursday, June 4, 2026 - "Vermont Day"

7:15 - 7:50 AM   Continental Breakfast

7:50 - 8:00   Introductory Remarks - Anya S. Streeter, MD, FAAFP, IBCLC
Welcoming Remarks -  Michelle Dorwart, MD, President, Vermont Academy of Family Physicians

8:00 - 8:45   Cancer Screening in Primary Care - Improving Population Health - Michelle Cangiano, MD

8:45 - 9:30   POCUS - What's in it for Me? - Benjamin Clements, MD

9:30 - 10:00   Break and Exhibits

10:00 - 10:45   Perimenopause: Symptoms, Risks and Management - Kirsten Berggren, PhD, FNP

10:45 - 11:45   Code Blue: Resuscitating Trust in Medicine - Tim Lahey, MD, MMSc, HEC-C, FACP

11:45 AM - 12:00 PM   Family Medicine Department Awards

12:00 - 1:15   Lunch

1:15 - 2:00   Common Questions from Primary Care for the Geneticist - Julie Refkin, MD, MPH

2:00 - 2:45   Food and Mood: Using Culinary Medicine to Promote Mental Health - Sravan Kakani, MD

2:45 - 3:15   Break and Exhibits

3:15 - 4:15   Family Oral Health and What Primary Care Can Do to Promote Healthy Smiles - Katie Merrick, DMD, MPH

4:15 - 5:00   Journal Club on Demand with Open Evidence - John King, MD, MPH

5:00 PM   Adjourn

Friday, June 5, 2026

7:30 AM   Continental Breakfast

8:00 - 8:45   Transition to Hospice Conversations - Ann Laramee, MS, ANP-BC, ACNS, ACHPN, FHFSA 

8:45 - 9:30   Skin Cancer at the Front Line: What Primary Care Needs to Know - Melanie Bui, MD, PhD

9:30 - 10:15   Considerations for Prescribing Menopausal Hormone Therapy - Kirsten Berggren, PhD, FNP

10:15 - 10:30   Break

10:30 - 11:15   ADHD - How to Evaluate and Treat in Primary Care - Sara Pawlowski, MD

11:15 - 12:00 PM   Zebra Soup: POTS, hEDS, MCAS, ME/CFS - Jessica Faraci, MD

12:00 PM   Conference Adjourn
 

Doubletree by Hilton

870 Williston Road in South Burlington, Vermont

Group Rates: $190.50 per night (excluding applicable taxes)
To reserve a room visit the DoubleTree by Hilton Group Rate webpage or call: 1-800-445-8667 and request the group rate for the "Family Medicine Course"
Doubletree by Hilton Hotel Webpage

A limited number of rooms are available, please make reservations by May 11, 2026.
Any reservations after that date are subject to availability and regular pricing. 

Please make your reservations early as our room blocks have filled in the past. 

If a room is needed on this date or later, please contact us at uvmcmie@med.uvm.edu for assistance.

Course Director:

Anya Streeter, MD, FAAFP, IBCLC 
Associate Professor of Family Medicine
Director of Fourth Year Electives and Specialty Advising, Family Medicine
Robert Larner, M.D. College of Medicine at the University of Vermont 

In support of improving patient care, The Robert Larner College of Medicine at the University of Vermont is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Vermont designates this live event for a maximum of 20.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program has been reviewed and is acceptable for up to 20.75 Nursing Contact Hours.              

The AAFP has reviewed The 52nd Annual Family Medicine Course and deemed it acceptable for up to 20.75 Live AAFP Prescribed credits. Term of Approval is from 06/02/2026 to 06/05/2026. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

This conference has been approved for up to 2.75 Pharmacotherapeutic credits. 

This conference has been approved for up to 1.5 credit in Prescribing Controlled Substances. This conference has been approved for up to 1.5 MATE Act credits.

This conference has been approved for up to 0.75 credits in Hospice/Palliative Care/Pain Management

Meeting Disclaimer:  Regarding materials and information received during this educational event, the views, statements, and recommendations expressed during this activity represent those of the authors and speakers and do not necessarily represent the views of the University of Vermont.

      Relevant Financial Relationships*:

All those with control of content (speakers, planners, moderators, reviewers, staff) who have relevant financial relationships with “ineligible companies” are listed below.  (An “ineligible company” is defined as those whose primary business is producing, marketing, selling, reselling or distributing healthcare products used by or on patients.)

 

Financial Interests to Disclose Relationships have been Mitigated*:

• Julie Refkin, MD –AstraZeneca, Novartis, Alnylam Pharmaceuticals, Insmed, Natera, Veeva Pharmaceuticals, United Therapeutics, Roche, Eli Lilly, Johnson & Johnson – Mutual Fund Investments
• Matthew Gilbert, MD - Novo Nordisk - Advisory Board
• David Kaminsky, MD - MGC Diagnostics, Inc – Speaker
  
   

 *Note: All relevant financial relationships, if any were listed above, have been mitigated.  All others in control of content have no relevant financial relationships with ineligible companies.

The following speakers have indicated they will be discussing the unlabeled use of a commercial product:

• Kirsten Berggren, MD - will present information on the use of hormone therapy for symptoms other than vasomotor symptoms, genitourinary symptoms and osteoporosis prevention
• Anja Jokela, MD – will present information on estrogen, testosterone, spirolactone, bicalutamide, and progesterone used off-label for gender affirming in accordance with international guidelines
• Katie Marvin, MD – will present information on using sublocade for tapering

• Jessica Faraci, MD – will present information on medications that can be used off label to help POTS, hEDS, MCAS and ME/CFS, as there are no FDA approved treatments yet

   

  Support received from Ineligible Companies:  None

   

*Having a financial relationship with an ineligible company, or discussing an unlabeled use of an ineligible product, may not prevent a speaker from making a presentation. However, the existence of the relationship must be made known to the planning committee prior to the conference, so that any relevant financial interest may be mitigated prior to the talk.